Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
16.04
-1.11 (-6.47%)
At close: Jul 25, 2025, 4:00 PM
16.06
+0.02 (0.12%)
After-hours: Jul 25, 2025, 7:59 PM EDT
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $5,040 → $2,640 | Strong Buy | Maintains | $5,040 → $2,640 | +16,358.85% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $3,840 → $5,040 | Strong Buy | Maintains | $3,840 → $5,040 | +31,321.45% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $28,800 | Buy | Maintains | $28,800 | +179,451.12% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $36,000 → $28,800 | Buy | Maintains | $36,000 → $28,800 | +179,451.12% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $61,200 | Buy | Initiates | $61,200 | +381,446.13% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $61,200 | Buy | Initiates | $61,200 | +381,446.13% | Apr 30, 2021 |